ZURICH, June 5 (Reuters) - Swiss contract drug manufacturer Lonza Group on Friday named Roche executive Pierre-Alain Ruffieux as its new chief executive effective from Nov. 1.
Ruffieux is now head of global pharma technical operations at Roche, Lonza said in a statement. Before that he was a manager at Novartis and has over 20 years experience in biopharmaceuticals. (Reporting by Michael Shields Editing by Shri Navaratnam)
Our Standards: The Thomson Reuters Trust Principles.